Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

bibf

bibf is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 5
Pipeline programs 2
News articles 0
Drug details — bibf
Class
—
Route
—
Patents
5
Programs
2
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

bibf is an FDA-listed pharmaceutical active ingredient.

Key facts

INN bibf

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX Phase 3 · Teva Pharma · Asthma
  2. mFOLFOX6 + BIBF 1120 Phase 2 · Galmed Pharmaceuticals · Colorectal Cancer

Related patents

Browse patents

  1. US 8975246

    Bile acid or bile salt fatty acid conjugates

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8110564

    Bile acid or bile salt fatty acid conjugates

    Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7501403

    Bile acid or bile salt fatty acid conjugates

    Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 6589946

    Bile salt conjugates

    Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6384024

    Bile salt conjugates

    Expires Mon May 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is bibf?

bibf is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.